VJ2-22123-44233
3 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 006 / PR
- Registered
- 2022-04-28
- Relationship
- Child or adolescent in my care
- Guardian
- 6SW-75398-35647
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-19
Dose 1 — Pfizer-BioNTech
-
2021-05-10
Dose 2 — Pfizer-BioNTech
-
2022-02-10
Dose 3 — Pfizer-BioNTech
-
2022-04-28
Registered in v-safe
-
2022-05-12
Survey response — 3 months, dose 3, dependentMedDRA: SARS-CoV-2 test negative, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid antigen home test positive on April 28. PCR test positive on April 29. And PCR test negative on May 3rd.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-19 | Pfizer-BioNTech | No |
| 2 | 2021-05-10 | Pfizer-BioNTech | No |
| 3 | 2022-02-10 | Pfizer-BioNTech | No |
Free text
Release 11 — 3 months, dose 3, dependent
Symptoms: Covid antigen home test positive on April 28. PCR test positive on April 29. And PCR test negative on May 3rd.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release